Posted By Coherent Market Insights
Posted on September 17, 2021
Global Molecular Quality Control Market – Insights
Molecular quality control tests molecular diagnostic products. It also recognizes defects and monitors the efficacy of in vitro nucleic acid testing procedures for viral load assays and healthcare-associated infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and sexually transmitted diseases.
Statistics:
The global molecular cytogenetics market was valued at US$ 1,970.8 Mn in 2019 and is forecast to reach a value of US$ 11,129.1 Mn by 2027 at a CAGR of 24.2% between 2020 and 2027.
Global Molecular Quality Control Market: Drivers
Increasing launch of new products is expected to propel growth of the global molecular quality control market over the forecast period. For instance, in April 2019, Bruker Corporation BRKR launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries. Similarly, in July 2016, Bio-Rad Laboratories, Inc. launched Amplichek Quality Control, a quality control system for molecular diagnostic testing of infectious diseases.
Request for Sample Copy of Report: https://www.coherentmarketinsights.com/insight/request-sample/2491
Global Molecular Quality Control Market: Restraints
Molecular quality control systems are prone to inaccurate genetic tests, which is expected to limit growth of the global molecular quality control market. For instance, in August 2017, Invitae Corporation identified a quality control issue with a hereditary cancer test conducted on patients suffering from a rare genetic variant in the MSH2 gene, which is associated with the Lynch syndrome. The test provided false, negative results.
Global Molecular Quality Control Market: Regional Analysis
North America is expected to account for the largest market share in the global molecular quality control market over the forecast period. This is attributed to increasing launches of new products. For instance, in December 2018, Microbiologics, Inc. launched two new panels, Group A Streptococcus (GAS) and respiratory molecular assays, for quality control processes. These two panels include convenient features such as multiplexed pellets, swabs that mimic patient sample processing, and room temperature storage.
The market in Asia Pacific is driven by increasing partnership activities by key players. For instance, in June 2016, Thermo Fisher Scientific Inc. partnered with West China Hospital of Sichuan University to improve R&D and diagnostics in pathology.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/2491
Reasons to Purchase this Report:
Current and future of global Molecular Quality Control Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Global Molecular Quality Control Market: Competitive Landscape
Major players operating in the global molecular quality control market include, Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Maine Molecular Quality Controls, Inc., Quidel, Qnostics, Bio-Rad Laboratories, Roche Diagnostics, Microbiologics, Inc., and Theranostica.
Global Molecular Quality Control Market: Key Developments
Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio, For instance, in February 2018, Randox Laboratories partnered with Qnostics to access to the Qnostics molecular range of products for sales and distribution purposes.
Global Molecular Quality Control Market Taxonomy
By Product Type
- Independent Control
- Instrument Specific- Control
- DNA Sequencing and NGS (Next Generation Sequencing)
- PCR (Polymer Chain Reaction)
- Others
By Analyte Type
- Single Analyte
- Multi Analyte
By Application
- Oncology
- Genetic Testing
- Infectious Diseases
- Others
By End User
- Clinical Laboratories
- Hospitals and Clinics
- Academic and Research Institutes
- IVD Manufacturers
- Contract Research Organizations
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Molecular Cytogenetics Market 2021 Estimated to Reach a Valuation of US$ 11,129.1 Mn by 2027, at a CAGR of 45.7% Over the Forecast Period of 2027, Covering COVID-19 impact Analysis – Coherent Market Insights appeared first on Gatorledger.
Global Molecular Quality Control Market – Insights
Molecular quality control tests molecular diagnostic products. It also recognizes defects and monitors the efficacy of in vitro nucleic acid testing procedures for viral load assays and healthcare-associated infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and sexually transmitted diseases.
Statistics:
The global molecular cytogenetics market was valued at US$ 1,970.8 Mn in 2019 and is forecast to reach a value of US$ 11,129.1 Mn by 2027 at a CAGR of 24.2% between 2020 and 2027.
Global Molecular Quality Control Market: Drivers
Increasing launch of new products is expected to propel growth of the global molecular quality control market over the forecast period. For instance, in April 2019, Bruker Corporation BRKR launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries. Similarly, in July 2016, Bio-Rad Laboratories, Inc. launched Amplichek Quality Control, a quality control system for molecular diagnostic testing of infectious diseases.
Request for Sample Copy of Report: https://www.coherentmarketinsights.com/insight/request-sample/2491
Global Molecular Quality Control Market: Restraints
Molecular quality control systems are prone to inaccurate genetic tests, which is expected to limit growth of the global molecular quality control market. For instance, in August 2017, Invitae Corporation identified a quality control issue with a hereditary cancer test conducted on patients suffering from a rare genetic variant in the MSH2 gene, which is associated with the Lynch syndrome. The test provided false, negative results.
Global Molecular Quality Control Market: Regional Analysis
North America is expected to account for the largest market share in the global molecular quality control market over the forecast period. This is attributed to increasing launches of new products. For instance, in December 2018, Microbiologics, Inc. launched two new panels, Group A Streptococcus (GAS) and respiratory molecular assays, for quality control processes. These two panels include convenient features such as multiplexed pellets, swabs that mimic patient sample processing, and room temperature storage.
The market in Asia Pacific is driven by increasing partnership activities by key players. For instance, in June 2016, Thermo Fisher Scientific Inc. partnered with West China Hospital of Sichuan University to improve R&D and diagnostics in pathology.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/2491
Reasons to Purchase this Report:
Current and future of global Molecular Quality Control Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Global Molecular Quality Control Market: Competitive Landscape
Major players operating in the global molecular quality control market include, Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Maine Molecular Quality Controls, Inc., Quidel, Qnostics, Bio-Rad Laboratories, Roche Diagnostics, Microbiologics, Inc., and Theranostica.
Global Molecular Quality Control Market: Key Developments
Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio, For instance, in February 2018, Randox Laboratories partnered with Qnostics to access to the Qnostics molecular range of products for sales and distribution purposes.
Global Molecular Quality Control Market Taxonomy
By Product Type
- Independent Control
- Instrument Specific- Control
- DNA Sequencing and NGS (Next Generation Sequencing)
- PCR (Polymer Chain Reaction)
- Others
By Analyte Type
- Single Analyte
- Multi Analyte
By Application
- Oncology
- Genetic Testing
- Infectious Diseases
- Others
By End User
- Clinical Laboratories
- Hospitals and Clinics
- Academic and Research Institutes
- IVD Manufacturers
- Contract Research Organizations
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Molecular Cytogenetics Market 2021 Estimated to Reach a Valuation of US$ 11,129.1 Mn by 2027, at a CAGR of 45.7% Over the Forecast Period of 2027, Covering COVID-19 impact Analysis – Coherent Market Insights appeared first on Gatorledger.
